PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsSelected biotech news

BioNews

Selected biotech news

Published 9 June 2009 posted in News and appears in BioNews 40

Author

BioNews

PET BioNews

Speculation about a merger between pharmaceutical giants Glaxo Wellcome and SmithKline Beecham has been recently resumed. A leaked report has suggested that Sir Richard Sykes may step down earlier than expected from his position as chairman of Glaxo Wellcome to take an academic position at Imperial College, London. He was...

Speculation about a merger between pharmaceutical giants Glaxo Wellcome and SmithKline Beecham has been recently resumed. A leaked report has suggested that Sir Richard Sykes may step down earlier than expected from his position as chairman of Glaxo Wellcome to take an academic position at Imperial College, London. He was due to retire in 2002. Previous merger talks between the two companies broke down in 1998. Renewed hopes for the merger had arisen in December when SmithKline Beecham's chief executive, Jan Leschly announced he too was retiring early, in April of this year.


Meanwhile, in response to 'customer concern', the spearheads of the genetically modified (GM) crop trials in the UK have banned GM food from their own staff canteen. Granada Food Services have removed the modified products from the menu in Monsanto's canteen at it's High Wycombe base. The ban applies to all food outlets owned and operated by Granada. The move has been welcomed by campaigners against the use of GM ingredients in food, and farm-scale crop trials. Friends of the Earth has claimed that even Monsanto's own caterers had 'no confidence' in the company's products. Monsanto has denied that the decision was an embarrassment for the company and described the Granada decision to reduce customer choice and to make decisions on behalf of customers as 'ironic'. He said that Monsanto in-house canteens were run on different policies and that they use notices stating 'some products may contain GMOs'(genetically modified organism) as their staff are happy to eat foods sprayed with fewer chemicals'.

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Republican backs stem cell research in US Senate

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856